Lori Macomber serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Lori Macomber has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 15, 2025 involved receiving (via award) 43,650 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 15, 2025 | KPTI | $0 | Award | 43,650 | $N/A | Discretionary |
Lori Macomber currently holds 54,316 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lori Macomber has been a net neutral trader of KPTI stock. They have purchased $0 and sold $0 worth of shares.
Lori Macomber's most recent insider trade was on Oct 15, 2025, when they sold 43,650 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted